Abstract/Details

A vaccinia recombinant virus: Comparative evaluations among free-ranging, immunocompetent, and immunodeficient hosts


1994 1994

Other formats: Order a copy

Abstract (summary)

An orally efficacious vaccinia-rabies glycoprotein (V-RG) recombinant virus holds promise for wildlife rabies control. Due to thymidine kinase gene inactivation, the V-RG virus is attenuated. However, it may retain parental vaccinia characteristics for accidental mucous membrane infection and other complications in immunocompromised hosts. In these studies, neonatal, prednisolone-treated, and CDV$\sp1$-infected raccoons, FIV+, FeLV+, and dually-infected FeLV+, FIP+ cats, and athymic nude and SCID mice were utilized to evaluate V-RG in host models for specific vaccinia contraindications. Additionally, during the first North American V-RG field release on Parramore Island, VA, 887 free-ranging raccoons were live-trapped and examined for vaccinia-like lesions. No lesions suggestive of V-RG virus were demonstrated. The V-RG virus was recovered from tonsils of two, biomarker-positive vaccination area raccoons on days two and four following bait distribution. Survivorship was not different between baited and non-baited areas. In laboratory studies among 52 raccoons, two received 20 times the field dose per os, one dam nursing four 17 day-old kits received 10 times the field dose, eight raccoons received one vaccine-laden bait each, six were inoculated with one field dose at seven conjunctival and oral mucosal sites, 14 were less than 25 days-old upon oral, intradermal, ocular, or intranasal exposure, 21 received V-RG intradermally of which four were pretreated with prednisolone, and two had canine distemper. Notable findings in raccoons were limited to focal microscopic ulcerations at scarification sites. In 24 experimentally-infected FIV+, FeLV+, FeLV+ and FIP+, and uninfected cats, oral and intradermal inoculation of V-RG vaccine produced no clinically detectable adverse effects. In athymic nude mice, multi-systemic infection followed severe intradermal V-RG inoculation, but with a decrease in positive tissues and viral titers over time. In SCID mice, V-RG was innocuous by the oral route. Parenteral V-RG inoculation produced progressive lesions but at a significantly slower rate than with vaccinia. Administration of vaccinia immune globulin and hydroxyphosphonylmethoxypropylcytosine (HPMPC) resulted in regression of V-RG infection in SCID mice. ftn$\sp1$CDV-Canine distemper virus. FIV-Feline immunodeficiency virus. FeLV-Feline leukemia virus. FIP-Feline infectious peritonitis. SCID-Severe combined immunodeficiency.

Indexing (details)


Subject
Veterinary services;
Animal diseases;
Forestry
Classification
0778: Veterinary services
0476: Animal diseases
0478: Forestry
Identifier / keyword
Biological sciences
Title
A vaccinia recombinant virus: Comparative evaluations among free-ranging, immunocompetent, and immunodeficient hosts
Author
Hanlon, Cathleen Alma
Number of pages
205
Publication year
1994
Degree date
1994
School code
0175
Source
DAI-B 55/05, Dissertation Abstracts International
Place of publication
Ann Arbor
Country of publication
United States
Advisor
Rupprecht, Charles E.
University/institution
University of Pennsylvania
University location
United States -- Pennsylvania
Degree
Ph.D.
Source type
Dissertations & Theses
Language
English
Document type
Dissertation/Thesis
Dissertation/thesis number
9427544
ProQuest document ID
304120461
Copyright
Database copyright ProQuest LLC; ProQuest does not claim copyright in the individual underlying works.
Document URL
http://search.proquest.com/docview/304120461
Access the complete full text

You can get the full text of this document if it is part of your institution's ProQuest subscription.

Try one of the following:

  • Connect to ProQuest through your library network and search for the document from there.
  • Request the document from your library.
  • Go to the ProQuest login page and enter a ProQuest or My Research username / password.